The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model
Foundayo (orforglipron) is a prescription weight management pill approved for adults living with obesity, or adults who are overweight and have at least one weight-related health condition such as high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease

Ingredients: Step 1: Water(Aqua), Glycerin, Butylene Glycol, Niacinamide, Propanediol, Methylpropanediol, Caprylic/Capric Triglyceride, 1,2-Hexanediol, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Alcohol Denat., PVP, Polysorbate 20, Ammonium Acryloyldimethyltaurate/VP Copolymer, Glutathione, Sorbitan Isostearate, Ethylhexylglycerin, Fragrance(Parfum), Menthyl Lactate, Adenosine, Glycine, Disodium EDTA, Serine, Glutamic Acid, Melia Azadirachta Leaf Extract, Aspartic Acid, Leucine, Melia Azadirachta Flower Extract, Leucojum Aestivum Bulb Extract, Curcuma Longa (Turmeric) Root Extract, Alanine, Lysine, Arginine, Tyrosine, Phenylalanine, Valine, Threonine, Proline, Isoleucine, Histidine, Methionine, Cysteine, Ocimum Sanctum Leaf Extract, Corallina Officinalis Extract, Tocopherol, Ascorbic Acid
rda Pickart L, Margolina A (2018)
Mol cell
10.1007/s12032-010-9746-2 191 VijayanA